Karyopharm Therapeutics Inc赞助的临床试验
总计2964个结果
-
GSO Global Clinical Research BVKaryopharm Therapeutics Inc终止
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics Inc撤销
-
GSO Global Clinical Research BVKaryopharm Therapeutics Inc完全的
-
St. Jude Children's Research HospitalKaryopharm Therapeutics Inc完全的急性髓系白血病 (AML) | 急性淋巴细胞白血病 (ALL) | 骨髓增生异常综合征 (MDS) | 混合表型急性白血病 (MPAL)美国
-
Washington University School of MedicineKaryopharm Therapeutics Inc完全的
-
Washington University School of MedicineKaryopharm Therapeutics Inc招聘中
-
Georgetown UniversityHackensack Meridian Health; Karyopharm Therapeutics Inc终止
-
St. Jude Children's Research HospitalKaryopharm Therapeutics Inc终止
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics Inc终止
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics Inc撤销
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics Inc完全的
-
Tulane University School of MedicineKaryopharm Therapeutics Inc撤销难治性多发性骨髓瘤 | 复发性多发性骨髓瘤
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics Inc完全的
-
Sanjay MohanAbbVie; Karyopharm Therapeutics Inc主动,不招人
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics Inc尚未招聘急性髓性白血病 | 复发性急性髓性白血病 | 难治性急性髓性白血病 | 难治性骨髓增生异常综合征 | 复发性骨髓增生异常综合征美国
-
Alice MimsKaryopharm Therapeutics Inc完全的复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
Kari KendraKaryopharm Therapeutics Inc完全的
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc完全的
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc完全的
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics Inc完全的
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics Inc招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc终止
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc完全的
-
Jennifer WoyachKaryopharm Therapeutics Inc主动,不招人复发性成人弥漫性大细胞淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性小淋巴细胞淋巴瘤 | 幼淋巴细胞白血病 | 难治性慢性淋巴细胞白血病美国
-
Bhavana BhatnagarKaryopharm Therapeutics Inc完全的急性髓性白血病 | 继发性急性髓性白血病 | 未经治疗的成人急性髓性白血病美国
-
Canadian Cancer Trials GroupRoche Pharma AG; Janssen, LP; Karyopharm Therapeutics Inc招聘中
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics Inc招聘中难治性急性髓性白血病 | 急性髓性白血病,复发 | 复发中模糊谱系的急性白血病 | 不明确谱系的难治性急性白血病美国
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics Inc招聘中
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes Foundation主动,不招人复发性急性淋巴细胞白血病 (ALL) | 难治性急性淋巴细胞白血病 (ALL) | 复发性急性髓性白血病 (AML) | 难治性急性髓性白血病 (AML) | 复发性混合谱系白血病 | 难治性混合谱系白血病 | 复发性双表型白血病 | 难治性双表型白血病 | 急变期的慢性粒细胞白血病 (CML)美国
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics Inc主动,不招人
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics Inc完全的
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.完全的
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.完全的地理萎缩 | 干性年龄相关性黄斑变性
-
Therapeutics, Inc.完全的
-
Therapeutics, Inc.完全的